Shaping the Future of Ovarian Cancer Treatment at Penn

Terri Loring of Philadelphia is an ovarian cancer survivor.

One in 57 women will be diagnosed with ovarian cancer this year, and most women have advanced disease at the time of diagnosis because ovarian cancer may have no symptoms in its early stages.

The Penn Ovarian Cancer Research Center is working to establish an Ovarian Cancer Tumor Center to facilitate the procurement of ovarian tumor tissue at the time of surgery. Cells from the tumor issue can then be used to develop personalized vaccine therapies, which could eventually lead to improved survival and quality of life for women with ovarian cancer.

In this video, Terri shares her story of survivorship, and George Coukos, MD, PhD, of the The Penn Ovarian Cancer Research Center talks about research at Penn that is shaping the future of ovarian cancer treatment.

Learn more about ovarian cancer treatment at the Abramson Cancer Center.